H. Franklin Herlong

1.9k total citations
25 papers, 1.4k citations indexed

About

H. Franklin Herlong is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, H. Franklin Herlong has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 12 papers in Hepatology and 9 papers in Surgery. Recurrent topics in H. Franklin Herlong's work include Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (6 papers) and Gallbladder and Bile Duct Disorders (4 papers). H. Franklin Herlong is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (6 papers) and Gallbladder and Bile Duct Disorders (4 papers). H. Franklin Herlong collaborates with scholars based in United States and Canada. H. Franklin Herlong's co-authors include Willis C. Maddrey, Robert R. Recker, Gary Gordon, David A. Blake, Daniel A. Goldstein, Stephen P. Spielberg, Henry A. Pitt, John K. Boitnott, John Boitnott and Esteban Mezey and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

H. Franklin Herlong

24 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Franklin Herlong United States 16 652 580 361 191 140 25 1.4k
Gagan Sood United States 16 1.0k 1.5× 1.1k 1.9× 739 2.0× 205 1.1× 125 0.9× 35 1.8k
Giorgio La Villa Italy 28 1.4k 2.1× 967 1.7× 580 1.6× 327 1.7× 163 1.2× 68 2.3k
Kamal G. Ishak United States 8 355 0.5× 389 0.7× 208 0.6× 206 1.1× 209 1.5× 8 1.2k
Rolf Schauer Germany 23 558 0.9× 338 0.6× 739 2.0× 156 0.8× 56 0.4× 45 1.5k
William P. Baldus United States 22 1.1k 1.7× 878 1.5× 460 1.3× 214 1.1× 71 0.5× 32 2.1k
Sukru Emre United States 23 1.0k 1.5× 609 1.1× 1.3k 3.7× 154 0.8× 61 0.4× 45 1.9k
Udeme D. Ekong United States 21 824 1.3× 551 0.9× 1.0k 2.8× 230 1.2× 310 2.2× 53 2.0k
Claudia O. Zein United States 17 1.0k 1.6× 1.7k 3.0× 381 1.1× 89 0.5× 142 1.0× 32 2.1k
W. Lauchart Germany 19 1.0k 1.6× 572 1.0× 1.1k 3.0× 307 1.6× 57 0.4× 85 1.9k
Z. Varghese United Kingdom 17 254 0.4× 244 0.4× 247 0.7× 180 0.9× 99 0.7× 55 1.0k

Countries citing papers authored by H. Franklin Herlong

Since Specialization
Citations

This map shows the geographic impact of H. Franklin Herlong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Franklin Herlong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Franklin Herlong more than expected).

Fields of papers citing papers by H. Franklin Herlong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Franklin Herlong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Franklin Herlong. The network helps show where H. Franklin Herlong may publish in the future.

Co-authorship network of co-authors of H. Franklin Herlong

This figure shows the co-authorship network connecting the top 25 collaborators of H. Franklin Herlong. A scholar is included among the top collaborators of H. Franklin Herlong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Franklin Herlong. H. Franklin Herlong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mitchell, Mack C., Thomas A. Kerr, & H. Franklin Herlong. (2020). Current Management and Future Treatment of Alcoholic Hepatitis.. Gastroenterología y Hepatología. 16(4). 178–189. 11 indexed citations
2.
Torres, Harrys A., Parag Mahale, Boris Blechacz, et al.. (2015). Effect of Hepatitis C Virus Infection in Patients With Cancer: Addressing a Neglected Population. Journal of the National Comprehensive Cancer Network. 13(1). 41–50. 19 indexed citations
3.
Nathan, Hari, H. Franklin Herlong, Ahmet Gürakar, et al.. (2014). Clinical Decision-Making by Gastroenterologists and Hepatologists for Patients with Early Hepatocellular Carcinoma. Annals of Surgical Oncology. 21(6). 1844–1851. 7 indexed citations
4.
Herlong, H. Franklin, et al.. (2006). Treatment of refractory ascites. Current Treatment Options in Gastroenterology. 9(6). 530–537. 7 indexed citations
5.
Gebo, Kelly A., H. Franklin Herlong, Michael Torbenson, et al.. (2002). Role of liver biopsy in management of chronic hepatitis C: A systematic review. Hepatology. 36(5 Suppl 1). s161–s172. 177 indexed citations
6.
Ahrendt, Steven A., Henry A. Pitt, Anthony N. Kalloo, et al.. (1998). Primary Sclerosing Cholangitis. Annals of Surgery. 227(3). 412–423. 86 indexed citations
7.
Herlong, H. Franklin. (1994). Approach to the Patient with Abnormal Liver Enzymes. Hospital Practice. 29(11). 32–38. 15 indexed citations
8.
Rothstein, Jeffrey D. & H. Franklin Herlong. (1989). Neurologic Manifestations of Hepatic Disease. Neurologic Clinics. 7(3). 563–578. 20 indexed citations
9.
Burdick, James F., Georgia B. Vogelsang, William J. Smith, et al.. (1988). Severe Graft-versus-Host Disease in a Liver-Transplant Recipient. New England Journal of Medicine. 318(11). 689–691. 144 indexed citations
10.
Cameron, John L., Henry A. Pitt, Michael J. Zinner, et al.. (1988). Resection of Hepatic Duct Bifurcation and Transhepatic Stenting for Sclerosing Cholangitis. Annals of Surgery. 207(5). 614–622. 48 indexed citations
11.
Diehl, Anna Mae, John K. Boitnott, H. Franklin Herlong, et al.. (1985). Effect of Parenteral Amino Acid Supplementation in Alcoholic Hepatitis. Hepatology. 5(1). 57–63. 71 indexed citations
12.
Cameron, John L., Bob W. Gayler, Hilary Sanfey, et al.. (1984). Sclerosing Cholangitis. Annals of Surgery. 200(1). 54–60. 36 indexed citations
13.
Wang, Ko Pen, Peter Yang, David F. Hutcheon, et al.. (1983). A new method of injection sclerotherapy of esophageal varices. Gastrointestinal Endoscopy. 29(1). 38–40. 4 indexed citations
14.
Cameron, John L., Bob W. Gayler, H. Franklin Herlong, & Willis C. Maddrey. (1983). Sclerosing cholangitis: biliary reconstruction with Silastic transhepatic stents.. PubMed. 94(2). 324–30. 43 indexed citations
15.
Cameron, J. L., H. Franklin Herlong, Hilary Sanfey, et al.. (1983). The Budd-Chiari Syndrome. Annals of Surgery. 198(3). 335–346. 73 indexed citations
16.
Herlong, H. Franklin, Robert R. Recker, & Willis C. Maddrey. (1982). Bone Disease in Primary Biliary Cirrhosis: Histologic Features and Response to 25-Hydroxyvitamin D. Gastroenterology. 83(1). 103–108. 114 indexed citations
17.
Herlong, H. Franklin, Robert Russell, & Willis C. Maddrey. (1981). Vitamin A and zinc therapy in primary biliary cirrhosis. Hepatology. 1(4). 348–351. 50 indexed citations
18.
Spielberg, Stephen P., Gary Gordon, David A. Blake, Daniel A. Goldstein, & H. Franklin Herlong. (1981). Predisposition to Phenytoin Hepatotoxicity Assessed in Vitro. New England Journal of Medicine. 305(13). 722–727. 181 indexed citations
19.
Buse, Maria G., et al.. (1976). THE EFFECT OF DIABETES, INSULIN AND WALLERIAN DEGENERATION ON LEUCINE METABOLISM OF ISOLATED RAT SCIATIC NERVES. Journal of Neurochemistry. 27(6). 1339–1345. 15 indexed citations
20.
Buse, Maria G., et al.. (1976). The Effect of Diabetes, Insulin, and the Redox Potential on Leucine Metabolism by Isolated Rat Hemidiaphragm. Endocrinology. 98(5). 1166–1175. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gagan Sood Breakdown of academic impact, for papers by Giorgio La Villa Breakdown of academic impact, for papers by Kamal G. Ishak Breakdown of academic impact, for papers by Rolf Schauer Breakdown of academic impact, for papers by William P. Baldus Breakdown of academic impact, for papers by Sukru Emre Breakdown of academic impact, for papers by Udeme D. Ekong Breakdown of academic impact, for papers by Claudia O. Zein Breakdown of academic impact, for papers by W. Lauchart Breakdown of academic impact, for papers by Z. Varghese
Rankless by CCL
2026